Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system

BMC Microbiology

Volumn 7, Issue , 2007, Pages

  Brigante, Gioconda R ^a   Luzzaro, Francesco A ^a   Pini, Beatrice ^a   Lombardi, Gianluigi ^a   Sokeng, Gertrude ^a   Toniolo, Antonio Q ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; GLYCOPEPTIDE; MACROLIDE; PENICILLIN G; STREPTOMYCIN; TEICOPLANIN; ANTIINFECTIVE AGENT;

ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE; ANTIBIOTIC RESISTANCE; AUTOMATION; BACTERIAL INFECTION; COMPARATIVE STUDY; DRUG EFFECT; ENTEROCOCCUS; EVALUATION; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; STREPTOCOCCUS; STREPTOCOCCUS INFECTION;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; AUTOMATION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 34250357144     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-7-46     Document Type: Article

References (24)

1. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. RR Reinert S Reinert M van der Linden MY Cil A Al-Lahham P Appelbaum, Antimicrob Agents Chemother 2005 49 2903 2913 15980367 10.1128/AAC.49.7.2903-2913.2005
2. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). AN Treitman PR Yarnold J Warren GA Noskin, J Clin Microbiol 2005 43 462 463 15635016 10.1128/JCM.43.1.462-463.2005
3. Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002. RM Prabhu KE Piper LM Baddour JM Steckelberg WR Wilson R Patel, Antimicrob Agents Chemother 2004 48 4463 4465 15504884 10.1128/AAC.48.11.4463-4465.2004
4. Antimicrobial susceptibility patterns of β-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). KA Gordon ML Beach DJ Biedenbach RN Jones PR Rhomberg AH Mutnick, Diagn Microbiol Infect Dis 2002 43 157 162 10.1016/S0732-8893(02)00374-7 12088624
5. Characterization of fluoroquinolone-resistant β-hemolytic Streptococcus spp. Isolated in North America and Europe including ffthe first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: Report from the SENTRY Antimicrobial Surveillance Program (1997-2004). DJ Biedenbach MA Toleman TR Walsh RN Jones, Diagn Microbiol Infect Dis 2006 55 119 127 10.1016/j.diagmicrobio.2005.12.006 16530373
6. Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement M100-S16. Clinical and Laboratory Standards Institute, Clinical and Laboratory Standards Institute, Wayne, PA 2006
7. Identification of glycopeptide-resistant enterococci by VITEK 2 system and conventional and real-time polymerase chain reaction. A Eisner G Gorkiewicz G Feierl E Leitner J Köfer HH Kessler E Marth, Diagn Microbiol Infect Dis 2005 53 17 21 10.1016/j.diagmicrobio.2005.04.001 16182075
8. Evaluation of the Vitek 2 system for rapid identification of clinical isolates of gram-negative bacilli and members of the family Streptococcaceae. PJ Gavin JR Warren AA Obias SM Collins LR Peterson, Eur J Clin Microbiol Infect Dis 2002 21 869 874 12525922
9. Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. M Ligozzi C Bernini MG Bonora M de Fatima J Zuliani R Fontana, J Clin Microbiol 2002 40 1681 1686 11980942 10.1128/JCM.40.5.1681-1686.2002
10. Evaluation of the automated Phoenix system for potential routine use in the clinical microbiology laboratory. JL Donay D Mathieu P Fernandes C Prégermain P Bruel A Wargnier I Casin FX Weill PH Lagrange JL Herrmann, J Clin Microbiol 2004 42 1542 1546 15071001 10.1128/JCM.42.4.1542-1546.2004
11. Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix automated microbiology system. A Endimiani F Luzzaro A Tamborini G Lombardi V Elia R Belloni A Toniolo, New Microbiol 2002 25 323 329 12173774
12. Two-center collaborative evaluation of the performance of the BD Phoenix automated microbiology system for identification and antimicrobial susceptibility testing of Enterococcus spp. and Staphylococcus spp. AM Fahr U Eigner M Armbrust A Caganic G Dettori C Chezzi L Bertoncini M Benecchi MG Menozzi, J Clin Microbiol 2003 41 1135 1142 12624042 10.1128/JCM.41.3.1135-1142. 2003
13. Manual and automated instrumentation for identification of Enterobacteriaceae and other aerobic gram-negative bacilli. CM O'Hara, Clin Microbiol Rev 2005 18 147 162 15653824 10.1128/CMR.18.1.147-162.2005
14. Evaluation of the BD Phoenix automated microbiology system SMIC/ID panel for identification and antimicrobial susceptibility testing of Streptococcus spp. Y Hirakata J Matsuda M Nakano T Hayashi S Tozaka T Takezawa H Takahashi Y Higashiyama Y Miyazaki S Kamihira S Kohno, Diagn Microbiol Infect Dis 2005 53 169 173 10.1016/j.diagmicrobio.2005.06.003 16243478
15. Evaluation of the BD Phoenix SMIC/ID, a new streptococci identification and antimicrobial susceptibility panel, for potential routine use in a university-based clinical microbiology laboratory. K Kanemitsu H Kunishima K Inden M Hatta H Harigae K Ishizawa M Kaku, Diagn Microbiol Infect Dis 2005 53 101 105 10.1016/j.diagmicrobio.2005.05.016 16168613
16. What happened to the streptococci: overview of taxonomic and nomenclature changes. R Facklam, Clin Microbiol Rev 2002 15 613 630 12364372 10.1128/CMR.15.4.613-630.2002
17. Enterococcus. LM Teixeira RR Facklam, Manual of Clinical Microbiology American Society for Microbiology, Washington, DC, Murray PR, Barron EJ, Jorgensen JH, Pfaller MA, Yolken RH, 8 2003 422 433
18. Evaluation of the Vitek 2 system for susceptibility testing of Streptococcus pneumoniae isolates. WHF Goessens N Lemmens-den Toom J Hageman PWM Hermans M Sluijter R de Groot HA Verbrugh, Eur J Clin Microbiol Infect Dis 2000 19 618 622 10.1007/s100960000332 11014625
19. Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. U Eigner A Schmid U Wild D Bertsch A-M Fahr, J Clin Microbiol 2005 43 3829 3834 16081919 10.1128/JCM.43.8.3829-3834.2005
20. Validation of VITEK 2 4.01 software for detection, identification, and classification of glycopeptide-resistant enterococci. M Abele-Horn L Hommers R Trabold M Frosch, J Clin Microbiol 2006 44 71 76 16390951 10.1128/JCM.44.1.71- 76.2006
21. Development of in vitro susceptibility testing criteria and quality control parameters. Approved guideline-second edition. National Committee for Clinical Laboratory Standards, Document M23-A2, National Committee for Clinical Laboratory Standards, Wayne, Pa 2001
22. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin. PC Kohner R Patel JR Uhl KM Garin MK Hopkins LT Wegener FR Cockerill III, J Clin Microbiol 1997 35 3258 3263 9399530
23. Use of the Phoenix automated system for identification of Streptococcus and Enterococcus spp. G Brigante F Luzzaro A Bettaccini G Lombardi F Meacci B Pini S Stefani A Toniolo, J Clin Microbiol 2006 44 3263 3267 16954258 10.1128/JCM.00299-06
24. Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR. F Depardieu B Perichon P Courvalin, J Clin Microbiol 2004 42 5857 5860 15583325 10.1128/JCM.42.12.5857- 5860.2004